209 related articles for article (PubMed ID: 11157895)
1. Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy.
Dagan R; Klugman KP; Craig WA; Baquero F
J Antimicrob Chemother; 2001 Feb; 47(2):129-40. PubMed ID: 11157895
[TBL] [Abstract][Full Text] [Related]
2. Introduction: the goals of antimicrobial therapy.
Song JH
Int J Infect Dis; 2003 Mar; 7 Suppl 1():S1-4. PubMed ID: 12839701
[TBL] [Abstract][Full Text] [Related]
3. Short-duration therapy for respiratory tract infections.
Goff DA
Ann Pharmacother; 2004 Sep; 38(9 Suppl):S19-23. PubMed ID: 15226490
[TBL] [Abstract][Full Text] [Related]
4. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections.
Andes D; Anon J; Jacobs MR; Craig WA
Clin Lab Med; 2004 Jun; 24(2):477-502. PubMed ID: 15177850
[TBL] [Abstract][Full Text] [Related]
5. Implications for antimicrobial prescribing of strategies based on bacterial eradication.
Klugman KP
Int J Infect Dis; 2003 Mar; 7 Suppl 1():S27-31. PubMed ID: 12839705
[TBL] [Abstract][Full Text] [Related]
6. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of community-acquired respiratory tract infections.
Calbo E; Garau J
Respiration; 2005; 72(6):561-71. PubMed ID: 16354997
[TBL] [Abstract][Full Text] [Related]
7. Rational use of antibiotics to treat respiratory tract infections.
File TM; Hadley JA
Am J Manag Care; 2002 Aug; 8(8):713-27. PubMed ID: 12212759
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.
Moise-Broder PA; Forrest A; Birmingham MC; Schentag JJ
Clin Pharmacokinet; 2004; 43(13):925-42. PubMed ID: 15509186
[TBL] [Abstract][Full Text] [Related]
9. [Microbiological causes of antibiotic therapy failure in respiratory tract infections].
Kozioł-Montewka M
Pol Merkur Lekarski; 2011 May; 30(179):373-6. PubMed ID: 21675146
[TBL] [Abstract][Full Text] [Related]
10. Of bugs and drugs. A guide through the labyrinth of antimicrobial therapy for respiratory tract infections.
Singh J; Arrieta AC
Postgrad Med; 1999 Nov; 106(6):47-54; quiz 252. PubMed ID: 10576002
[TBL] [Abstract][Full Text] [Related]
11. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
[TBL] [Abstract][Full Text] [Related]
12. The use of pharmacokinetic/pharmacodynamic principles to predict clinical outcome in paediatric acute otitis media.
Dagan R
Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S127-30. PubMed ID: 17980558
[TBL] [Abstract][Full Text] [Related]
13. The challenge of prescribing treatment for respiratory tract infections.
Nicolau DP
Am J Manag Care; 2000 May; 6(8 Suppl):S419-26. PubMed ID: 10977481
[TBL] [Abstract][Full Text] [Related]
14. Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin.
Fogarty CM; Kohno S; Buchanan P; Aubier M; Baz M
J Antimicrob Chemother; 2003 Apr; 51(4):947-55. PubMed ID: 12654763
[TBL] [Abstract][Full Text] [Related]
15. Optimizing antimicrobial therapy in respiratory-tract infections: new agents, new strategies. Introduction.
Schentag JJ
Am J Health Syst Pharm; 1999 Nov; 56(22 Suppl 3):S3. PubMed ID: 10580733
[No Abstract] [Full Text] [Related]
16. [Sense and nonsense in antibiotic therapy for respiratory tract infections].
Domej W; Flögel E; Tilz GP; Demel U
Internist (Berl); 2005 Jul; 46(7):795-9. PubMed ID: 15815891
[TBL] [Abstract][Full Text] [Related]
17. Resistant pathogens in respiratory tract infections in older people.
Bonomo RA
J Am Geriatr Soc; 2002 Jul; 50(7 Suppl):S236-41. PubMed ID: 12121519
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial drug use and resistance among respiratory pathogens in the community.
Low DE
Clin Infect Dis; 2001 Sep; 33 Suppl 3():S206-13. PubMed ID: 11524720
[TBL] [Abstract][Full Text] [Related]
19. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.
Taccetti G; Campana S; Festini F; Mascherini M; Döring G
Eur Respir J; 2005 Sep; 26(3):458-61. PubMed ID: 16135728
[TBL] [Abstract][Full Text] [Related]
20. Problems and prospectives in the antibiotic treatment of lower respiratory tract infections.
Cazzola M
Pulm Pharmacol; 1994 Jun; 7(3):139-52. PubMed ID: 7827433
[No Abstract] [Full Text] [Related]
[Next] [New Search]
